Application of ginsenoside Rb3 in preparing medicines for treating depressive disorder

A technology of ginsenoside and depression, which is applied in the field of medicine to achieve the effect of making full use of resources, reducing waste, and avoiding treatment
CN101856365AInactive Publication Date: 2010-10-13SUN YAT SEN UNIV

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SUN YAT SEN UNIV
Publication Date
2010-10-13
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the field of medicine or natural medicine chemistry, and particularly relates to application of a natural product-ginsenoside Rb3 in preparing a medicine for treating depressive disorder. In the application, ginsenoside Rb3 is directly extracted and obtained from panax notoginseng, ginseng or American ginseng; the dosage is 3.0-20.0mg per kilo of weight each day. Through organically regulating in vivo neurotransmitter and neural network balance and actions of multiple ways and multiple targets such as promoting nerve growth and the like, ginsenoside Rb3 is applied in preparing medicine for treating depressive disorder, so that obvious anti-depression effect is obtained. In addition, ginsenoside Rb3 can be extracted and obtained through traditional Chinese medicine or natural plants, and can be supplied for patients with depressive disorder to be continuously taken for a long period. The ginsenoside Rb3 has clear effective substance, obvious therapeutic effect, small toxic or side effect and definite action mechanism, and is in favor of radically treating depressive disorder and avoiding recurrence of depressive disorder.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of medicine or natural medicinal chemistry, and in particular relates to the application of a natural product in the preparation of medicines for treating depression. Background technique

[0002] Depression is a common mental illness. The so-called Depressive Disorder refers to a mood disorder syndrome characterized by low mood. It usually manifests as long-term low mood, grief, and loss of interest. , self-blame and low self-esteem, slow thinking, slow action, listlessness, loss of appetite, and even extreme self-harm thoughts such as suicide in severe cases. Depression is a disease with high incidence, high recurrence rate, high disability rate and high burden rate. According to the statistics of the World Health Organization, depression has become the fourth largest disease in the world, and it is predicted that by 2020, it may become the second largest disease in the world after coronary heart disease. Depressi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More